+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

Company Snapshots: US Pharmaceuticals - Product Thumbnail Image

Company Snapshots: US Pharmaceuticals

  • Newsletter
  • November 2024
  • 35 Pages
  • United States
From
Market Access, Pricing and Reimbursement of Oncology Medicines in the 5EU - Product Thumbnail Image

Market Access, Pricing and Reimbursement of Oncology Medicines in the 5EU

  • Report
  • September 2018
  • 162 Pages
  • Global
From
Industry Snapshots: US Pharmaceuticals - Product Thumbnail Image

Industry Snapshots: US Pharmaceuticals

  • Newsletter
  • November 2024
  • 50 Pages
  • United States
From
Industry Snapshots: UK Pharmaceuticals - Product Thumbnail Image

Industry Snapshots: UK Pharmaceuticals

  • Newsletter
  • November 2024
  • 50 Pages
  • United Kingdom
From
Asia Pacific Filgrastim Market By Drug Type, By Indication, By Distribution Channel, By Country, Opportunity Analysis and Industry Forecast, 2021 - 2027 - Product Thumbnail Image

Asia Pacific Filgrastim Market By Drug Type, By Indication, By Distribution Channel, By Country, Opportunity Analysis and Industry Forecast, 2021 - 2027

  • Report
  • November 2021
  • 82 Pages
  • Asia Pacific
From
North America Filgrastim Market By Drug Type, By Indication, By Distribution Channel, By Country, Opportunity Analysis and Industry Forecast, 2021 - 2027 - Product Thumbnail Image

North America Filgrastim Market By Drug Type, By Indication, By Distribution Channel, By Country, Opportunity Analysis and Industry Forecast, 2021 - 2027

  • Report
  • November 2021
  • 71 Pages
  • North America
From
LAMEA Filgrastim Market By Drug Type, By Indication, By Distribution Channel, By Country, Opportunity Analysis and Industry Forecast, 2021 - 2027 - Product Thumbnail Image

LAMEA Filgrastim Market By Drug Type, By Indication, By Distribution Channel, By Country, Opportunity Analysis and Industry Forecast, 2021 - 2027

  • Report
  • November 2021
  • 82 Pages
  • Africa, Middle East
From
Europe Filgrastim Market By Drug Type, By Indication, By Distribution Channel, By Country, Opportunity Analysis and Industry Forecast, 2021 - 2027 - Product Thumbnail Image

Europe Filgrastim Market By Drug Type, By Indication, By Distribution Channel, By Country, Opportunity Analysis and Industry Forecast, 2021 - 2027

  • Report
  • November 2021
  • 82 Pages
  • Europe
From
Pharma Industry Mergers and Acquisitions Deals by Top Themes in 2022 - Thematic Intelligence - Product Thumbnail Image

Pharma Industry Mergers and Acquisitions Deals by Top Themes in 2022 - Thematic Intelligence

  • Report
  • February 2023
  • 22 Pages
  • Global
From
Rheumatoid Arthritis (RA) Therapy Area Report - Product Thumbnail Image

Rheumatoid Arthritis (RA) Therapy Area Report

  • Report
  • February 2022
  • 65 Pages
  • Global
Complement C5 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 4 or C5) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Complement C5 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 4 or C5) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 168 Pages
  • Global
From
Lung Transplant Rejection Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Lung Transplant Rejection Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 51 Pages
  • Global
From
20s Proteasome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

20s Proteasome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 89 Pages
  • Global
From
Chronic Kidney Disease-Mineral Bone Disorders (CKD-MBD): Competitive Landscape to 2027 - Product Thumbnail Image

Chronic Kidney Disease-Mineral Bone Disorders (CKD-MBD): Competitive Landscape to 2027

  • Report
  • March 2019
  • 47 Pages
  • Global
From
Migraine - Pipeline Review, H2 2020 - Product Thumbnail Image

Migraine - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 342 Pages
  • Global
From
Bone Marrow Transplant Rejection Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Bone Marrow Transplant Rejection Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • April 2022
  • 555 Pages
  • Global
From
Behcet Disease Global Clinical Trials Review, H1, 2020 - Product Thumbnail Image

Behcet Disease Global Clinical Trials Review, H1, 2020

  • Clinical Trials
  • June 2020
  • 103 Pages
  • Global
From
Global Oncology Drugs Market 2018-2024 - Product Thumbnail Image

Global Oncology Drugs Market 2018-2024

  • Report
  • March 2018
  • 102 Pages
  • Global
From
PharmSource: Contract Manufacturing of Novel In-Licensed Drugs - 2020 Edition - Product Thumbnail Image

PharmSource: Contract Manufacturing of Novel In-Licensed Drugs - 2020 Edition

  • Report
  • February 2020
  • 24 Pages
  • Global
From
Heart Failure: Global Drug Forecast and Market Analysis to 2028 - Product Thumbnail Image

Heart Failure: Global Drug Forecast and Market Analysis to 2028

  • Report
  • December 2019
  • 190 Pages
  • Global
From
Loading Indicator